Clinical Trials Browser

Phase 1/2 × OTHER × AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase × Clear all

NCT02151448 2020-07-20

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

Phase 1/2 Completed

64 enrolled 18 charts

Peritoneal Neoplasms